Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a common heart disease with a prevalence of 1 in 500 in the general population. Several mutations in genes encoding cardiac proteins have been found in HCM patients, but these changes do not predict occurrence or prognosis and the molecular mechanisms underlying...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCI Insight
Egile Nagusiak: Kimura, Hirotaka, Eguchi, Satoshi, Sasaki, Junko, Kuba, Keiji, Nakanishi, Hiroki, Takasuga, Shunsuke, Yamazaki, Masakazu, Goto, Akiteru, Watanabe, Hiroyuki, Itoh, Hiroshi, Imai, Yumiko, Suzuki, Akira, Mizushima, Noboru, Sasaki, Takehiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5213877/
https://ncbi.nlm.nih.gov/pubmed/28097232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89462
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak